Skip to main content

Advertisement

SpringerLink
Log in

Surgical management of papillary thyroid carcinoma: an overview

  • Review Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

The surgical management of papillary thyroid carcinoma remains contentious and the optimal surgical strategy has not been yet established. The extent of thyroid resection has been the nub of this debate. Literature lacks prospective randomized controlled trials that could help put this debate to rest, and these have been labeled as being impractical. Consequently, large retrospective studies and expert opinion have constituted the basis of clinical practice guidelines. Recent American Thyroid Association and National Comprehensive Cancer Network guidelines consider a conservative approach in the form of a thyroid lobectomy sufficient for low-risk disease and that total thyroidectomy remains the standard of care in the presence of high-risk features. Nevertheless, many authorities still advocate more aggressive therapy for low-risk disease. The challenge in standardizing the surgical strategy to papillary thyroid carcinoma is mainly related to a major tumor characteristic: the high frequency of occult cancerous foci whether within the thyroid gland itself or within loco-regional lymph nodes as this tumor characteristic has been incriminated for a higher risk of recurrent disease and its adverse sequelae. The purpose of this article is to provide an overview of the surgical management of papillary thyroid carcinoma and the main arguments surrounding this hotly debated topic. All evidences for this review article were drawn from PubMed articles in English language mostly cross-referenced with international guideline statements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morris L, Myssiorek D (2010) Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 200:454–461. doi:10.1016/j.amjsurg.2009.11.008

    Article  PubMed  PubMed Central  Google Scholar 

  2. Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322. doi:10.1001/jamaoto.2014.1

    Article  PubMed  Google Scholar 

  3. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E (2015) Thyroid cancer mortality and incidence: a global overview. Int J Cancer 136:2187–2195. doi:10.1002/ijc.29251

    Article  PubMed  Google Scholar 

  4. Udelsman R, Lakatos E, Ladenson P (1996) Optimal surgery for papillary thyroid carcinoma. World J Surg 20:88–93

    Article  CAS  PubMed  Google Scholar 

  5. Mazzaferri EL (2000) Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 6:469–476. doi:10.4158/EP.6.6.469

    Article  CAS  PubMed  Google Scholar 

  6. Haugen BR, Alexander EK, Bible KC, Doherty G, Mandel SJ, Nikiforov YE, Pacini F, Randolph G, Sawka A, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward D, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133. doi:10.1089/thy.2015.0020

    Article  PubMed  PubMed Central  Google Scholar 

  7. Haddad RI et al (2016) NCCN clinical practice guidelines in oncology (NCCN Guidelines®) for thyroid carcinoma version 1.2016. © 2016 National Comprehensive Cancer Network, Inc. http://NCCN.org

  8. Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260:601–615

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–381

    Article  PubMed  PubMed Central  Google Scholar 

  10. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214

    Article  Google Scholar 

  11. Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA (2015) Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab 100:115–121. doi:10.1210/jc.2014-3039

    Article  CAS  PubMed  Google Scholar 

  12. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC Cancer Staging Manual, 7th edn. Springer, New York

    Google Scholar 

  13. Gyorki DE, Untch B, Tuttle RM, Shaha AR (2013) Prophylactic central neck dissection in differentiated thyroid cancer: an assessment of the evidence. Ann Surg Oncol 20:2285–2289

    Article  PubMed  Google Scholar 

  14. Kim SH, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY (2016) Differences in the recurrence and survival of patients with symptomatic and asymptomatic papillary thyroid carcinoma: an observational study of 11,265 person-years of follow-up. Thyroid. 26:1472–1479

    Article  CAS  PubMed  Google Scholar 

  15. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407

    PubMed  PubMed Central  Google Scholar 

  16. Grogan RH, Kaplan SP, Cao H, Weiss RE, Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL, Schechter RB (2013) A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154:1436–1446. doi:10.1016/j.surg.2013.07.008

    Article  PubMed  Google Scholar 

  17. Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA (2015) Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol 33:2370–2375. doi:10.1200/JCO.2014.59.8391

    Article  PubMed  Google Scholar 

  18. Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, Fish S, Weber RS (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214–1216

    Article  PubMed  Google Scholar 

  19. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Esnaola NF, Cantor SB, Sherman SI, Lee JE, Evans DB (2001) Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 130:921–930

    Article  CAS  PubMed  Google Scholar 

  21. Macedo FI, Mittal VK (2015) Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: a meta-analysis. Surg Oncol 24:117–122. doi:10.1016/j.suronc.2015.04.005

    Article  PubMed  Google Scholar 

  22. Kim SK, Park I, Woo JW, Lee JH, Choe JH, Kim JH, Kim JS (2017) Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: analysis of 8,676 patients at a single institution. Surgery 161:485–492. doi:10.1016/j.surg.2016.07.037

    Article  PubMed  Google Scholar 

  23. Hirsch D, Levy S, Tsvetov G, Shimon I, Benbassat C (2014) Total versus hemithyroidectomy for small unilateral papillary thyroid carcinoma. Oncol Lett 7:849–853

    PubMed  Google Scholar 

  24. Balentine CJ, Domingo RP, Patel R, Laucirica R, Suliburk JW (2013) Thyroid lobectomy for indeterminate FNA: not without consequences. J Surg Res 184:189–192. doi:10.1016/j.jss.2013.05.076

    Article  PubMed  Google Scholar 

  25. Park HK, Kim DW, Ha TK, Choo HJ, Park YM, Jung SJ, Kim DH, Bae SK (2015) Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients. Endocr Res 40:49–53. doi:10.3109/07435800.2014.933975

    Article  CAS  PubMed  Google Scholar 

  26. Kluijfhout WP, Pasternak JD, Lim J, Kwon JS, Vriens MR, Clark OH, Shen WT, Gosnell JE, Suh I, Duh QY (2016) Frequency of high-risk characteristics requiring total thyroidectomy for 1–4 cm well-differentiated thyroid cancer. Thyroid 26:820–824. doi:10.1089/thy.2015.0495

    Article  CAS  PubMed  Google Scholar 

  27. Lang BH-H, Shek TWH, Wan KY (2016) The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1–4 cm: implications for completion thyroidectomy following lobectomy. Clin Endocrinol. doi:10.1111/cen.13165

    Google Scholar 

  28. Rosario PW, Mourão GF, Calsolari (2016) Apparently intrathyroid papillary thyroid carcinoma >1 and ≤4 cm: is the need for completion thyroidectomy common among patients submitted to lobectomy? Clin Endocrinol (Oxf) 85:150–151. doi:10.1111/cen.13034

    Article  Google Scholar 

  29. Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Shen WT, Gosnell JE, Suh I, Duh QY (2017) Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery 161:127–133. doi:10.1016/j.surg.2016.05.056

    Article  PubMed  Google Scholar 

  30. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885

    Article  PubMed  Google Scholar 

  31. Sevim T (2007) Risk factors for permanent laryngeal nerve paralysis in patients with thyroid carcinoma. Clin Otolaryngol 32:378–383

    Article  CAS  PubMed  Google Scholar 

  32. Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM, Shaha A, Shah JP (2012) Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 151:571–579

    Article  PubMed  Google Scholar 

  33. Ryu J, Ryu YM, Jung YS, Kim SJ, Lee YJ, Lee EK, Kim SK, Kim TS, Kim TH, Lee CY, Park SY, Chung KW (2013) Extent of thyroidectomy affects vocal and throat functions: a prospective observational study of lobectomy versus total thyroidectomy. Surgery 154:611–620. doi:10.1016/j.surg.2013.03.011

    Article  PubMed  Google Scholar 

  34. Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K (2014) Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg 38:68–79. doi:10.1007/s00268-013-2224-1

    Article  PubMed  Google Scholar 

  35. Hauch A, Al-Qurayshi Z, Randolph G, Kandil E (2014) Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann Surg Oncol 21:3844–3852. doi:10.1245/s10434-014-3846-8

    Article  PubMed  Google Scholar 

  36. Kwon H, Jeon MJ, Kim WG, Park S, Kim M, Song DE, Sung TY, Yoon JH, Hong SJ, Kim TY, Shong YK, Kim WB (2017) A comparison of lobectomy and total thyroidectomy for patients with papillary thyroid microcarcinoma: a retrospective individual risk factor matched cohort study. Eur J Endocrinol. doi:10.1530/EJE-16-0845

    Google Scholar 

  37. Kuba S, Yamanouchi K, Hayashida N, Maeda S, Adachi T, Sakimura C, Kawakami F, Yano H, Matsumoto M, Otsubo R, Sato S, Fujioka H, Kuroki T, Nagayasu T, Eguchi S (2016) Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: comparative analysis after propensity score matching: a multicenter study. Int J Surg. doi:10.1016/j.ijsu.2016.09.083

    PubMed  Google Scholar 

  38. Kandil E, Krishnan B, Noureldine SI, Yao L, Tufano RP (2013) Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Otorhinolaryngol Relat Spec 75:6–17. doi:10.1159/000345498

    Article  CAS  PubMed  Google Scholar 

  39. Li YJ, Wang YZ, Yi ZB, Chen LL, Zhou XD (2015) Comparison of completion thyroidectomy and primary total surgery for differentiated thyroid cancer: a meta-analysis. Oncol Res Treat 38:528–531. doi:10.1159/000440690

    Article  PubMed  Google Scholar 

  40. Leiker AJ, Yen TW, Cheung K, Evans DB, Wang TS (2013) Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of “suspicious for papillary thyroid cancer”. Surgery 154:1307–1313

    Article  PubMed  Google Scholar 

  41. Corso C, Gomez X, Sanabria A, Vega V, Dominguez LC, Osorio C (2014) Total thyroidectomy versus hemithyroidectomy for patients with follicular neoplasm. A cost-utility analysis. Int J Surg 12:837–842

    Article  CAS  PubMed  Google Scholar 

  42. Schvartz C, Bonnetain F, Dabakuyo S, Gauthier M, Cueff A, Fieffé S, Pochart JM, Cochet I, Crevisy E, Dalac A, Papathanassiou D, Toubeau M (2012) Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab 97:1526–1535. doi:10.1210/jc.2011-2512

    Article  CAS  PubMed  Google Scholar 

  43. Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I (2011) Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 117:4439–4446. doi:10.1002/cncr.26070

    Article  PubMed  PubMed Central  Google Scholar 

  44. Vaisman F, Momesso D, Bulzico DA, Pessoa CH, da Cruz MD, Dias F, Corbo R, Vaisman M, Tuttle RM (2013) Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J Thyroid Res 2013:398194. doi:10.1155/2013/398194

    Article  PubMed  PubMed Central  Google Scholar 

  45. Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, Seccia V, Sensi E, Romei C, Piaggi P, Torregrossa L, Sellari-Franceschini S, Basolo F, Vitti P, Elisei R, Miccoli P (2015) Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 100:1316–1324. doi:10.1210/jc.2014-3825

    Article  CAS  PubMed  Google Scholar 

  46. Conzo G, Calò PG, Sinisi AA, De Bellis A, Pasquali D, Iorio S, Tartaglia E, Mauriello C, Gambardella C, Cavallo F, Medas F, Polistena A, Santini L, Avenia N (2014) Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: a retrospective study of a large clinical series. Surgery 155:998–1005. doi:10.1016/j.surg.2014.02.010

    Article  PubMed  Google Scholar 

  47. Bardet S, Ciappuccini R, Quak E, Rame JP, Blanchard D, de Raucourt D, Babin E, Michels JJ, Vaur D, Heutte N (2015) Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer. J Clin Endocrinol Metab 100:132–140. doi:10.1210/jc.2014-1199

    Article  CAS  PubMed  Google Scholar 

  48. Hartl DM, Mamelle E, Borget I, Leboulleux S, Mirghani H, Schlumberger M (2013) Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg 37:1951–1958. doi:10.1007/s00268-013-2089-3

    Article  PubMed  Google Scholar 

  49. Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, Tufano RP, Tuttle RM, American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144–1152. doi:10.1089/thy.2012.0043

    Article  PubMed  Google Scholar 

  50. Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT, Kloos RT, Mazzaferri EL Sr, Peduzzi PN, Roman SA, Sippel RS, Sosa JA, Stack BC Jr, Steward DL, Tufano RP, Tuttle RM, Udelsman R, American Thyroid Association Surgical Affairs Committee (2012) American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22:237–244. doi:10.1089/thy.2011.0317

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrine Surgery, Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy

    Paolo Miccoli & Sohail Bakkar

  2. Department of Surgery, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan

    Sohail Bakkar

Authors
  1. Paolo Miccoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sohail Bakkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sohail Bakkar.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest or financial ties to disclose.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethic committee approval was waived because of the type of this study.

Informed consent

Informed consent was waived because of the type of this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miccoli, P., Bakkar, S. Surgical management of papillary thyroid carcinoma: an overview. Updates Surg 69, 145–150 (2017). https://doi.org/10.1007/s13304-017-0449-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-017-0449-5

Keywords

Search

Navigation